You are here:

bosentan 62.5mg 125mg film coated tablets (Tracleer)

Advice

In the absence of a submission from the holder of the marketing authorisation

bosentan (Tracleer) is not recommended for use within NHSScotland to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: bosentan 62.5mg 125mg film coated tablets (Tracleer)
SMC Drug ID: 485/08
Manufacturer: Actelion Pharmaceuticals UK Ltd
Indication: to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease
BNF Category:
Sub Category: 2.5 Hypertension and heart failure
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 9 June 2008

Back